+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Ear Infection Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4896041
  • Report
  • August 2020
  • Region: Global
  • 111 pages
  • Mordor Intelligence


  • Cipla Ltd
  • GlaxoSmithKline plc
  • Grace Medical
  • Johnson & Johnson
  • Novartis AG
  • Olympus Corporation
  • MORE
An ear infection occurs when a bacterial or viral infection that affects the inner, middle or outer ear. Ear infections can be painful because of inflammation and fluid buildup in the ear. Acute ear infection can cause mild pain and discomfort in the ear. However chronic cases can cause severe pain, loss of body balance, drainage of fluids from ear, headache and even hearing loss in some cases.

Smoke from a burning cigarette combined with exhaled smoke from a person who smokes increases unhealthy particles in the air, including those of nicotine and other toxins. This increases the microbe growth in such households, which increases the risk of ear infection. This is the major driving factor for the growth of this market. Other factors like unclean and unhealthy environment also increase the risk of ear infection, which leads to growth of ear infection treatment market. However high cost of surgical procedures in severe cases has been restraining the growth of this market.

Key Market Trends

Middle Ear Infection is Expected to Show a High Growth Rate Over the Forecast Period

Middle ear infection also referred to as otitis media, is the most common ear infection, especially in children. According to a study by Kaur R et al. published Pediatric Journal 2017, by 1 year of age, 23% of the children experienced more than one episodes acute otitis media (AOM). By 3 years of age, 60% had more than one episode of AOM, and nearly 24% had more than 3 such episodes. The peak incidence was reported to have occurred at 6 to 12 months of life. It is therefore found that the prevalence is very high for children. Hence the immediate treatment is very necessary. Thus, this treatment for a middle ear infection is expected to occupy a large share of the market.

North America Dominates the Market and Expected to do the Same in the Forecast Period

North America has been accounted for the largest market share of the followed by the Europe & Asia Pacific regions. The North America market is growing due to the largest contribution from the significantly growing market of the US as there are increasing number of surgeries coupled with the high expenditure on the health care.

However, US has also has a developed and structured healthcare system that encourages research and development among pharmaceutical companies and various research organizations. The healthcare system is also involved in spreading awareness regarding the treatment, which increases its demand. Hence, this region is expected to dominate the market.

Competitive Landscape

Majority of the key player involved in research and manufacturing of Ear Infection Treatment are established in developed countries. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market growth.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Cipla Ltd
  • GlaxoSmithKline plc
  • Grace Medical
  • Johnson & Johnson
  • Novartis AG
  • Olympus Corporation
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of the Ear Infection
4.2.2 Increasing Exposure to Cigarette Smoke
4.3 Market Restraints
4.3.1 High Cost and Complications related Surgical Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Infection
5.1.1 Inner Ear Infection
5.1.2 Middle Ear Infection
5.1.3 Outer Ear Infection
5.2 By Cause
5.2.1 Viral Infection
5.2.2 Bacterial Infection
5.3 By Type
5.3.1 Medication Antibiotics Analgesics AntiViral
5.3.2 Surgery
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Olympus Corporation
6.1.2 American Diagnostic Corporation
6.1.3 Pfizer plc
6.1.4 Novartis AG
6.1.5 Grace Medical
6.1.6 Sanofi S.A.
6.1.7 GlaxoSmithKline plc
6.1.8 Johnson & Johnson
6.1.9 Cipla Ltd

Note: Product cover images may vary from those shown
  • Olympus Corporation
  • American Diagnostic Corporation
  • Pfizer plc
  • Novartis AG
  • Grace Medical
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Cipla Ltd
Note: Product cover images may vary from those shown